Holdings
Sphera Funds Management LTD.
As of Sep 30, 2026, Sphera Funds Management LTD. reported 89 positions worth US$547M. Largest: Mineralys Therapeutics, Inc., Alnylam Pharmaceuticals, Inc. and Cytokinetics, Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | 1.32M | US$33.2M | −148K | Sep 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 121K | US$29.8M | +110K | Sep 30, 2026 |
| Cytokinetics, Incorporated | 362K | US$23.9M | +142K | Sep 30, 2026 |
| iShares Semiconductor ETF | 37,000 | US$21M | new | Sep 30, 2026 |
| BridgeBio Pharma, Inc. | 312K | US$20.5M | +66,371 | Sep 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 1.01M | US$18.9M | −7,328 | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 293K | US$17.6M | −35,304 | Sep 30, 2026 |
| Biogen Inc. | 75,763 | US$17.1M | −20,863 | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 502K | US$16.1M | +42,200 | Sep 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 25,795 | US$13M | +8,376 | Sep 30, 2026 |